Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry.
María Paz Martínez-VidalCristina Fernández-CarballidoLucia Otero VarelaFrancisco Javier Manero RuizYanira Pérez-VeraSara Manrique ArijaCristina Campos FernándezVega JovaníLorena ExpósitoBonifacio Álvarez LarioJavier García-GonzálezFernando Sánchez-AlonsoIsabel CastrejónPublished in: The Journal of rheumatology (2024)
No significant differences were found between treatments in long-term survival due to inefficacy or AEs.